APA (7th ed.) Citation

Rücker, F. G., Agrawal, M., Corbacioglu, A., Weber, D., Kapp-Schwoerer, S., Gaidzik, V. I., . . . Döhner, K. (2019). Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): Results from the AML Study Group. Blood, 134(19), . https://doi.org/10.1182/blood.2019001425

Chicago Style (17th ed.) Citation

Rücker, Frank Gert, et al. "Measurable Residual Disease Monitoring in Acute Myeloid Leukemia with T(8;21)(q22;q22.1): Results from the AML Study Group." Blood 134, no. 19 (2019). https://doi.org/10.1182/blood.2019001425.

MLA (9th ed.) Citation

Rücker, Frank Gert, et al. "Measurable Residual Disease Monitoring in Acute Myeloid Leukemia with T(8;21)(q22;q22.1): Results from the AML Study Group." Blood, vol. 134, no. 19, 2019, https://doi.org/10.1182/blood.2019001425.